Immersion Course on Comprehensive Lung Cancer Treatment and Surgical Innovation

  • Continuing Education
Harvard Medical School Quad with Gordon Hall in Background.

-

Registration Deadline: August 16

Master the latest, evidence-based strategies for tackling the complex challenges of lung cancer care in this immersive course, led by world-renowned faculty from Brigham and Women’s Hospital and Harvard Medical School.

  • In Person

This course requires in person attendance.

Brigham and Women's Hospital, Boston, MA

$400

This is the standard price, for a full list of profession pricing see below.
View All

Continuing Education Credits

Earn up to:
18.00 AMA PRA Category 1 Credit(s) ™
View All

Three Days

Please view the Schedule for a full description of the program.

On This Page

Overview

Sponsored by the Division of Thoracic and Cardiac Surgery at Brigham and Women’s Hospital and featuring faculty from Harvard Medical School, this course offers a multidisciplinary perspective on the latest advancements in lung cancer care.

Designed for thoracic surgeons, oncologists, pulmonologists, radiologists, pathologists, and trainees, the program integrates live surgical demonstrations, hands-on workshops, didactic sessions, and case-based panel discussions. Topics range from early diagnosis and staging to advanced surgical techniques, molecular testing, immunotherapy, and multimodal treatment strategies.

The course emphasizes a comprehensive approach to lung cancer management, addressing the unique challenges of integrating surgery, systemic therapy, and radiation in a multidisciplinary care model. Sessions also highlight innovations in technology, including robotic and minimally invasive surgical techniques, along with insights into real-world applications, and cutting-edge research.

Participants at all stages of their careers will benefit from exposure to world-renowned faculty and the opportunity to engage in collaborative discussions, ensuring they leave equipped with the knowledge and tools to optimize patient outcomes in lung cancer care.

Learning Objectives

  • Describe the advantages and technical considerations associated with the minimally invasive strategies in the management of basic and complex thoracic disorders.
  • Identify the factors leading to complications in minimally invasive robotic thoracic surgery for patients with lung cancer.
  • Identify the factors leading to complications in minimally invasive uniportal VATS for patients with lung cancer.
  • Explain the process by which technically advanced procedures may be incorporated into surgical practice.

Developed and Offered By:

  • Brigham and Women's Hospital logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Brigham and Women's Hospital.

Participant Types

Specialty Physicians

Schedule

All agenda sessions are in Eastern Time.

Day 1

Thursday, August 14, 2025

Breakfast

7:15-7:45 am

Welcome Remarks

7:45-8:00 am

Session I: | Diagnosis and Staging Updates in Very Early Stage Lung Cancer | Moderator - Scott J. Swanson, MD

8:00-8:40 am

AI in Lung Cancer: Why is Adoption Taking so Long?

Katherine Andriole

8:00-8:20 am

CT Lung Nodule Imaging: Definitions and Recommendations on Reporting

Mark Hammer

8:20-8:40 am

Debate

8:40-9:10 am

Debate: Strategies to Obtain Tissue Diagnosis

Pro Transthoracic Needle Biopsy - Mark Hammer; Pro Robotic Bronchoscopy - Matthew Pommerening; Conclusion & Voting - Scott Swanson

8:40-9:10 am

Session I: | Diagnosis and Staging Updates in Very Early Stage Lung Cancer | Moderator - Scott J. Swanson, MD

9:10-9:20 am

EBUS Accuracy for IMS in cN0 -1

Ricardo Oliveira

9:10-9:20 am

Debate

9:20-9:55 am

Debate: Strategies to Stage Mediastinum

Imaging Alone - Bruno Hochhegger; EBUS - Ricardo Oliveira; Upfront Surgery - Bernard J. Park; Conclusion and Voting - Scott Swanson

9:20-9:55 am

Session I: | Diagnosis and Staging Updates in Very Early Stage Lung Cancer | Moderator - Scott J. Swanson, MD

9:55-10:30 am

Challenging the Presenters: Clinical Cases

Bruno Hochhegger

9:55-10:30 am

Break

10:30-11:00 am

Session II: | Decision Making in Very Early-Stage NSCLC | Moderator - Thomas D'Amico, MD

11:00 am-12:30 pm

Update on SBRT for Early-Stage NSCLC

Kelly Fitzgerald

11:00-11:15 am

Neoadjuvant Therapy in cT2NO NSCLC

Bernard Park

11:15-11:30 am

Clinical Cases: Challenging the Audience

Paula Ugalde Figueroa

11:30 am-12:15 pm

Panel Discussion

Julia Rotow

12:15-12:30 pm

Lunch

12:30-1:30 pm

Session III: | Pathology and New Insights in Lung Cancer | Moderator - Paula Ugalde Figueroa, MD

1:30-4:00 pm

What's New in Thoracic Pathology

Igor Odintsov

1:30-1:50 pm

Circulating Tumor DNA: Are We Ready for Prime Time?

Lynette Sholl

1:50-2:10 pm

The Pathology Report Shows STAS: Now What?

Hassan Khalil

2:10-2:30 pm

Pathology Case Discussion: When Patient has a Molecular Driver Mutation

Lynette Sholl

2:30-3:30 pm

Panel Discussion/Q&A

Zofia Piotrowska

3:30-4:00 pm

Closing Remarks | Day 1 Conclusion

4:00-4:15 pm

Day 2

Friday, August 15, 2025

Breakfast

7:00-7:30 am

Welcome Remarks

Paula Ugalde Figueroa

7:30-7:45 am

Session IV: | Integrating Immunotherapy in Resectable NSCLC | Moderator - Isabelle Opitz, MD

7:45-8:30 am

Lung Cancer Multidisciplinary Care Pathways

Narjust Florez

7:45-8:00 am

Molecular Analysis: When and Which Tests to use?

Lecia Sequist

8:00-8:15 am

Limits to Surgical Resection in Stage III

Isabelle Opitz

8:15-8:30 am

Debate

8:30-8:55 am

Debate: Complete Genomic Profile

Yes, It's a Must! - Julia Rotow; No, It is a Waste of Time! - Benny Weksler; Conclusion and Voting - Isabelle Optiz

8:30-8:55 am

Session IV: | Integrating Immunotherapy in Resectable NSCLC | Moderator - Isabelle Opitz, MD

8:55-10:00 am

Managing Cases with Progression

Justin Gainor

8:55-9:05 am

Tumor Board: Real-World Challenging Cases

Paula Ugalde Figueroa; Bruno Hochhegger

9:05-9:45 am

Panel Discussion/Q&A

9:45-10:00 am

Break

10:00-10:20 am

Session IV: | Integrating Immunotherapy in Resectable NSCLC | Moderator - Isabelle Opitz, MD

10:20-10:40 am

Upcoming Targeted Therapies

David Barbie

10:20-10:40 am

Debate

10:40-11:30 am

Debate: How I Approach Oligometastatic Disease

Pro Surgery - Isabelle Optiz; Pro Radiation - Kelly Fitzgerald; Conclusion and Voting - Isabelle Optiz

10:40-11:05 am

Debate: Multistation N2 Disease Without Driver Mutation

Pro Surgery - Thomas D'Amico; Con - Narjust Florez; Conclusion and Voting - Isabelle Optiz

11:05-11:30 am

Session IV: | Integrating Immunotherapy in Resectable NSCLC | Moderator - Isabelle Opitz, MD

11:30 am-12:00 pm

Panel Discussion/Q&A

11:30 am-12:00 pm

Group Photo on HMS Steps

12:00-12:15 pm

Lunch

12:15-1:30 pm

Room 1 | EBUS & Cryo Cases

Hisashi Tsukada

1:30-5:00 pm

Room 2 | Robotic Lung Resection

Jon Wee

1:30-5:00 pm

Room 3 | ION and VATS Lung Resection

Matthew Pommerening; Paula Ugalde Figueroa

1:30-5:00 pm

How do I localize Lung Nodules

Santiago Figueroa

1:30-5:00 pm

How to define parenchymal margin

Thomas D'Amico

1:30-5:00 pm

Wedge or Segment for <2 cm Tumor?

Bernard Park

1:30-5:00 pm

N1 Disease During the Segmentectomy: Next Step?

Scott Swanson

1:30-5:00 pm

Update on 3D Reconstruction

Ricardo Terra

1:30-5:00 pm

Q&A Day 2 Wrap-up

Paula Ugalde Figueroa

5:00-5:15 pm

Day 3

Saturday, August 16, 2025

Breakfast

7:45-8:15 am

Welcome Remarks

Paula Ugalde Figueroa

8:15-8:30 am

Room 1 | Robotic Lung Resection

Matthew Rochefort

8:30 am-12:30 pm

Room 2 | VATS Lung Resection (Segmentectomy

Paula Ugalde Figueroa

8:30 am-12:30 pm

How I do EBUS for Clinical Stage II and III

Ricardo Oliveira

8:30 am-12:30 pm

How I Manage Lymphadenopathy Post Neoadjuvant Chemotherapy & Immunotherapy

Ricardo Terra

8:30 am-12:30 pm

Limits to Robotic Surgery in Chemotherapy and Immunotherapy Patient

Isabelle Opitz

8:30 am-12:30 pm

Type of Resections Post Chemotherapy & Immunotherapy

Benny Weksler

8:30 am-12:30 pm

How I Manage Vascular Infiltrations?

Thomas D'Amico

8:30 am-12:30 pm

Surgical Complications/Clinical Cases

8:30 am-12:30 pm

Q&A | Course Wrap-Up

Paula Ugalde Figueroa

12:30-1:00 pm

Optional Workshops

Wednesday, August 13 | 12:30-5:00 PM

Each participant may select one session, with a maximum of 25 participants per session.  

Optional workshops are not CME-accredited. For questions, email learn@hms.harvard.edu

  1. Esophageal Course:  
    Jon O. Wee, MD; Benny Weksler, MD; Humberto Oliveira, MD
  2. Robotic Surgery Course | Ion, MP, SP:
    Ricardo Terra, MD; Bernard Park, MD; Matthew Pommerening, M.D.  
  3. Segmentectomy Course:
    Paula Ugalde Figueroa, MD; Rian Hasson, MD; Bruno Hochhegger, MD
  4. Transplant & ECMO Course:
    Antonio Coppolino, III, MD; Raghu Seethala, MD; Diego Pardo, MD
  5. Complex Cases:
    Narjust Florez, MD; Isabelle Opitz, MD; Francisco Suarez, MD 
 

Faculty

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

Katherine Andriole, MD, PhD
Associate Professor of Radiology, Brigham and Women's Hospital

David Barbie, MD
Director, Lowe Center for Thoracic Oncology
Associate Director, Belfer Center for Applied Cancer Research
Physician
Associate Professor of Medicine, Harvard Medical School

Antonio Coppolino, III, MD
Associate Surgical Director, Lung Transplantation Program
Director of Ex Vivo Lung Perfusion, Brigham and Women's Hospital
Program Director, Lung Transplantation, Heart Transplantation, and Mechanical Circulatory Support Fellowship
Instructor in Surgery, Harvard Medical School

Santiago Figueroa, MD
Clinical University Hospital of Valencia

Kelly Fitzgerald, MD, PhD
Instructor in Radiation Oncology, Harvard Medical School 

Narjust Florez, MD
Associate Director, Cancer Care Equity Program; Assistant Professor of Medicine 

Justin Gainor, MD
Program Director, Center for Thoracic Cancers
Director, Targeted Immunotherapy
Associate Professor of Medicine at Harvard Medical School

Mark Hammer, MD
Associate Professor of Radiology, Harvard Medical School 

Rian Hasson, MD, MPH, FACS
Vice Chair for Diversity, Equity, and Inclusion, Department of Surgery
Associate Surgeon, Division of Thoracic Surgery; Member of the Faculty, Harvard Medical School

Bruno Hochhegger, MD, PhD
Vice Chair of Research, Professor of Thoracic Imaging, University of Florida 

Hassan Khalil, MD
Assistant Professor of Surgery, Harvard Medical School 

Igor Odinstov, MD
Clinical Fellow in Pathology

Humberto Oliveira, MD, PhD
Hospital de Base do Distrito Federal (Brazil)

Ricardo Oliveira, MD
IUCPQ, Quebec

Isabelle Opitz, MD
Head of Lung and Thoracic Oncology Center Comprehensive Cancer Center Zurich, University Hospital Zurich, Department of Thoracic Surgery

Diego Pardo, MD
Clinica Portoazul (Colombia)

Bernard J. Park, MD
Memorial Sloan Kettering Cancer Center 

Matthew Pommerening, MD, MS
Instructor in Surgery, Harvard Medical School 

Matthew Rochefort, MD
Chief, Thoracic Surgery, Milford Regional Medical Center
Associate Program Director, I6 Cardiothoracic Surgery Residency Program
Assistant Professor of Surgery, Harvard Medical School

Julia Rotow, MD
Clinical Director, Lowe Center for Thoracic Oncology
Director of Clinical Research
Physician
Assistant Professor of Medicine, Harvard Medical School

Raghu Seethala, MD, MS
Medical Director, ECMO Service
Director, Thoracic Surgical Intensive Care Unit
Co-Director, Cardiac Surgical Intensive Care Unit
Section Chief of Critical Care, Division of Thoracic and Cardiac Surgery
Assistant Professor of Emergency Medicine, Harvard Medical School

Lynette Marie Sholl, MD
Chief, Thoracic Pathology, Brigham and Women's Hospital
Associate Professor of Pathology, Harvard Medical School

Francisco Suarez, MD
Clínica Santa María (Chile)

Ricardo Terra, MD
Associate Professor of Thoracic Surgery, University of Sao Paulo Medical School, Chief of the Surgical Thoracic Oncology Division, Sao Paulo Cancer Institute

Hisashi Tsukada, MD, PhD
Assistant Professor of Surgery, Harvard Medical School

Jon Wee, MD
Section Chief, Esophageal Surgery
Director of Robotics in Thoracic Surgery
Co-Director of Minimally Invasive Thoracic Surgery
Assistant Professor of Surgery, Harvard Medical School

Location Information

Venue

Brigham and Women's Hospital  
75 Francis Street
Boston, MA 02115

Hotel Information

Westin Copley Plaza 
10 Huntington Avenue 
Boston, MA 02116

Special Course Rate: $289 per night  

A credit card is required to guarantee your reservation, and payment will be due at check-in.  

Book Your Reservation Today! 

Complete Your Registration

Started a registration? Log in to enroll today.

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Fee Disclaimer

Tuition for Immersion Course on Comprehensive Lung Cancer Treatment and Surgical Innovation is listed below. You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus and access to recordings after the course.

At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.

Review the cancellation policy.

Role Standard Price
Physician (MD/DO) $400.00
PA $200.00
Resident/Fellow $100.00
Allied Health Professional / Other $200.00

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Harvard Medical School designates this live activity for a maximum of 18.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with  AMA PRA Category 1 Credit™ for re-licensure.

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Provide Patient-Centered Care
  • Work in Interdisciplinary Teams
  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Professionalism
  • Systems-Based Practice

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

Program Topics

Program Specialties